If they start doing business in China, does it make sense to think about having a stock listing in Asia (e.g. Hong Kong)?
I could imagine that we could sell our product at first in china before the USA.
Even if we can finally submit BLA by end of February (I doubt it), it will take FDA the maximum of time they are allowed to use for the approval process ("fast track" my a*s).
If the FDA is too corrupt, then f*ck them. Maybe we should give CFDA a chance, despite the risk attached dealing with Chinese companies.